Gan & Lee Pharmaceuticals. reported earnings results for the first quarter ended March 31, 2022. For the first quarter, the company reported sales was CNY 689.99 million compared to CNY 548.6 million a year ago. Revenue was CNY 689.99 million compared to CNY 548.6 million a year ago. Net income was CNY 113.3 million compared to CNY 190.08 million a year ago. Basic earnings per share from continuing operations was CNY 0.2 compared to CNY 0.34 a year ago. Diluted earnings per share from continuing operations was CNY 0.2 compared to CNY 0.34 a year ago.